Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Orthopedics companies’ nightmare quarter
EP Vantage
Tue, 08/25/20 - 09:47 pm
Tags:
earnings, COVID-19, pandemic, Orthopedics, Medtronic, Thermofisher, Qiagen, ResMed, Zimmer Biomet, JNJ
J&J adds yet another multiple myeloma regimen to the Darzalex label as Sanofi rival jumps in
Endpoints
Fri, 08/21/20 - 12:32 pm
Tags:
JNJ, Darzalex, FDA, Multiple Myeloma
Johnson & Johnson to Launch Late-Stage Coronavirus Vaccine Trials in September
Motley Fool
Thu, 08/20/20 - 10:48 pm
Tags:
JNJ, clinical trials, Janssen Vaccines, COVID-19
J&J inks $6.5B Momenta buyout to bag autoimmune drug
Fierce Biotech
Wed, 08/19/20 - 11:06 am
Tags:
JNJ, Momenta Pharmaceuticals, M&A, myasthenia gravis
U.S. states seek $26.4 billion from drug firms in opioid litigation: WSJ
Reuters
Tue, 08/18/20 - 11:06 am
Tags:
JNJ, opioids, opioid crisis, litigation, McKesson, Cardinal Health, Amerisource Bergen
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Motley Fool
Sun, 08/16/20 - 10:44 pm
Tags:
Pfizer, biosimilars, Humira, Inflectra, Remsima, Remicade, autoimmune disease, JNJ
On heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe
Fierce Pharma
Thu, 08/13/20 - 11:58 pm
Tags:
JNJ, Europe, pandemic, vaccines, COVID-19
Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion
CNBC
Wed, 08/5/20 - 10:32 am
Tags:
JNJ, vaccines, COVID-19, government contract
FDA expands use of controversial J&J antidepressant
Beckers Hospital Review
Wed, 08/5/20 - 12:01 am
Tags:
FDA, JNJ, Spravato, treatment-resistant depression, major depressive disorder, ketamine
Merck scoops up a PhII J&J discard in a bargain-basement deal. And this time they’re shooting at NASH
Endpoints
Tue, 08/4/20 - 12:42 pm
Tags:
Merck, JNJ, South Korea, Hanmi Pharma, HM12525A, NASH
J&J COVID-19 vaccine candidate protects monkeys after single dose
Fierce Biotech
Thu, 07/30/20 - 11:28 pm
Tags:
JNJ, COVID-19, vaccines
J&J Vision debuts new try-it augmented reality tech application for Acuvue lenses in China
Fierce Pharma
Wed, 07/29/20 - 10:55 am
Tags:
JNJ Vision, JNJ, augmented reality, China, Acuvue, contact lens
Is Johnson & Johnson an Underdog in the COVID-19 Vaccine Race?
Motley Fool
Sun, 07/26/20 - 11:02 pm
Tags:
JNJ, vaccines, COVID-19
Pharma promises lawmakers, again and again, industry won’t cut corners with Covid-19 vaccines
Stat
Tue, 07/21/20 - 05:05 pm
Tags:
AstraZeneca, Pfizer, Merck, JNJ, Moderna Therapeutics, congress, vaccines, COVID-19
How much will it cost? And 5 other questions Congress could push Covid-19 vaccine makers to answer
Stat
Mon, 07/20/20 - 12:08 pm
Tags:
congress, vaccines, pandemic, COVID-19, AstraZeneca, Pfizer, JNJ, Merck, Moderna Therapeutics
J&J to start human trials for COVID-19 vaccine this week
Beckers Hospital Review
Mon, 07/20/20 - 10:25 am
Tags:
JNJ, COVID-19, vaccines, clinical trials, Belgium
J&J Alters Plans for Surgical Robotics Platform
Medical Devices and Diagnostics Industry
Sun, 07/19/20 - 11:18 pm
Tags:
JNJ, devices, robotic surgery
J&J-partnered MeiraGTx aims at Biogen with new eye gene therapy data
Endpoints
Sat, 07/18/20 - 12:11 pm
Tags:
JNJ, MeiraGTx, gene therapy, Retinitis pigmentosa, clinical trials
Johnson & Johnson's Revenue and Earnings Slipped in the Second Quarter
Motley Fool
Thu, 07/16/20 - 11:25 pm
Tags:
JNJ, earnings
Janssen’s Tremfya gets FDA approval for active psoriatic arthritis
Pharmaceutical Business Review
Wed, 07/15/20 - 10:20 am
Tags:
Janssen, JNJ, FDA, Tremfya, psoriatic arthritis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.